ENVALITH
株式会社 京葉銀行 logo

The Keiyo Bank, Ltd.

8544Prime MarketBanks

株式会社 京葉銀行 logo
The Keiyo Bank, Ltd.8544

Governance

The Board of Directors consists of 9 members, including 3 outside directors (as of the date of filing the Annual Securities Report). At the Annual General Meeting of Shareholders in June 2026, the company plans to transition to a company with an Audit and Supervisory Committee (following the transition, the board will consist of 15 members, including 7 outside directors). The company has established a Nomination and Compensation Advisory Committee, structured so that outside directors constitute a majority of its members.

Nomination Committee

Established

Compensation Committee

Established

Risk Management

The Risk Management Division centrally manages credit, market, liquidity, operational, system and other risks, and the company has established a Risk Management Committee and an ALM Committee. The compliance oversight function is placed within the Risk Management Division, which regularly convenes a Compliance Committee, and compliance officers are assigned to all sales branches and head office departments.

Shareholder Returns

For FY2026 (ending March 2026), the company paid an interim dividend of ¥19 and a year-end dividend of ¥23 (annual total ¥42), with a payout ratio of 31.8%. For FY2027 (ending March 2027), it forecasts an annual dividend of ¥66 (¥33 interim and ¥33 year-end), with a payout ratio expected to be 40.5%. Share buybacks are also being continued.

Dividend Policy

The basic policy is to allocate appropriately to stakeholders while maintaining sound management and strengthening internal reserves. Dividends are paid twice a year: an interim dividend (resolved by the Board of Directors) and a year-end dividend (resolved by the General Meeting of Shareholders). For FY2026 (ending March 2026), the annual dividend is ¥42 per share (¥19 interim plus ¥23 year-end), with a consolidated payout ratio of 31.8%. For FY2027 (ending March 2027), an annual dividend of ¥66 (¥33 interim plus ¥33 year-end) is forecast, with a payout ratio expected to be 40.5%.

Dividend

Paying

Share Buyback

Possible

Shareholder Benefits

None

ESG

The Company endorses the TCFD recommendations and has conducted scenario analysis for transition risk (cumulative credit-related costs of approximately ¥5.1 billion) and physical risk (up to approximately ¥2.2 billion). Regarding CO2 emissions, the Company targets a 50% reduction by FY2030 (ending March 2031) versus FY2013 levels and carbon neutrality by FY2050, with FY2025 results showing a 25.6% reduction versus FY2013. For ESG-related investment and loans, the Company targets a cumulative total of ¥1,400.0 billion from FY2021 to FY2030, with a cumulative total of ¥826.3 billion executed as of the end of FY2025. In terms of human capital, the Company has set targets of a 12% ratio of female managers (targeted for April 2027) and maintaining employee satisfaction of 80% or higher, and has been certified as an Excellent Health Management Corporation 2026 for five consecutive years.

Last updated: June 17, 2026